LifeSciVoiceFashion Trends and Culture

R&D
- Research & Development
  
  Oculis’ Phase 2 Study Explores OCS-05 for Optic Nerve Inflammation
  
  Editorial Team - January 9, 2025 0
  
  A phase 2 clinical trial has assessed the effectiveness and safety of OCS-05, a peptidomimetic small molecule developed by Oculis, for patients with optic...
  
  Research & Development
  
  Research finds Merck’s treatment of lung disease can lower chance of death
  
  Mohsin Riaz - November 28, 2024 0
  
  Merck has released that its drug, Winrevair, reduced the risk of death in patients suffering from a rare condition that causes high blood pressure...
  
  Research & Development
  
  GSK Responds to Pfizer’s RSV Approval with Data Aiming for Similar Approval in Younger Adults
  
  Editorial Team - October 29, 2024 0
  
  Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit certain high-risk subgroups of younger adults and could potentially serve a broader...
  
  Research & Development
  
  Developments in RNA Research Win Nobel Prizes for the Second Consecutive Year
  
  Editorial Team - October 11, 2024 0
  
  After last year’s Nobel Prize in Physiology or Medicine was awarded to Drew Weissman and Katalin Karikó for their work on mRNA vaccines, which...
Clinical
- Clinical
  
  Sling Therapeutics Challenges Tepezza in Thyroid Eye Disease Treatment
  
  Editorial Team - January 16, 2025 0
  
  Sling Therapeutics has achieved a milestone in the development of its oral treatment for thyroid eye disease (TED), linsitinib. In a recent phase 2b/3...
  
  Clinical
  
  J&J’s Lung Cancer Combo Outperforms Tagrisso in Survival Rates
  
  Editorial Team - January 14, 2025 0
  
  Johnson & Johnson has achieved a breakthrough in the treatment of non-small cell lung cancer (NSCLC), with its combination therapy of Rybrevant and Lazcluze...
  
  Clinical
  
  Blueprint Terminates Clinical-Stage CDK2 Inhibitor Program but Continues Breast Cancer Research
  
  Editorial Team - January 14, 2025 0
  
  Blueprint Medicines has announced the termination of its clinical-stage CDK2 inhibitor program, including the development of BLU-222, but reaffirmed its commitment to advancing preclinical...
  
  Clinical
  
  Sanofi and SK bioscience advance their 21-Valent vaccine to Phase 3
  
  Editorial Team - December 26, 2024 0
  
  Sanofi has announced a new step forward in its collaboration with SK bioscience, providing a €50 million ($52 million) upfront payment to propel their...
Commercial
- All Brand & Marketing
  
  Commercial
  
  Regenxbio And Nippon Sinyaku Pen $810M Gene Therapy Agreement
  
  Editorial Team - January 16, 2025 0
  
  Regenxbio has struck a strategic partnership valued at $810 million with Japan's Nippon Shinyaku to promote gene treatments aimed at the uncommon metabolic condition...
  
  Commercial
  
  Umoja Biopharma Secures $100 Million Series C Funding for Cell Therapy Advancements
  
  Editorial Team - January 16, 2025 0
  
  Umoja Biopharma has successfully closed a $100 million Series C funding round, marking a step forward for the company’s efforts to advance innovative cell...
  
  Commercial
  
  Tune Therapeutics Raises Whopping $175M to Bring Epigenetic Drug Into Clinic
  
  Editorial Team - January 14, 2025 0
  
  Investors are clearly in no doubt over the functionality of Tune Therapeutics’ epigenetic silencing drug, providing the biotech with an astounding $175 million in...
Technology
- Commercial
  
  Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
  
  Editorial Team - October 23, 2024 0
  
  Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight patterns. Wisp’s new weight care...
  
  Technology
  
  PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
  
  Editorial Team - September 26, 2024 0
  
  Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...
  
  Technology
  
  Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
  
  Editorial Team - August 8, 2024 0
  
  Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...
  
  Technology
  
  AI Firm Formation Bags $372 Series D Funding
  
  Editorial Team - June 30, 2024 0
  
  In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...
Insights
- Insights
  
  The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption
  
  Renato Rjavec - December 1, 2024 0
  
  A new independent survey of senior US pharma regulatory professionals suggests that commitment to AI investment is much higher than might be expected, although...
  
  Insights
  
  Improving life science R&D outcomes with AI
  
  Ben Sidders - November 8, 2024 0
  
  Maximizing the potential AI/data-driven model of drug discovery requires the technology’s full integration into R&D. Biorelate’s Dr Ben Sidders explains. Pharma R&D latest disruption is...
  
  Insights
  
  The medical device sector’s surging regulatory burden: how are suppliers coping?
  
  Mike Baird , Peter Muller - October 12, 2024 0
  
  Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes. Referencing new research, Peter Muller...
  
  Insights
  
  The Future of Gene Therapies: Three Trends
  
  Philip Cyr, Richard Macaulay , Andy Kinley - March 18, 2023 0
  
  “Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...
Podcast
Awards
- Life Sciences Voice Top Industry Leaders Award 2024 Nominations
- List of Winners of the Rising Stars Award 2024
More

Top Industry Leaders Award Winners 2022 - Complete List

Victor Bulto

President, Innovative Medicines US

Novartis

John C. Jacobs

President and CEO

Novavax

Alisha Alaimo

President, U.S. Organization

Biogen

Frank D. Lee

President and CEO

FORMA Therapeutics

John V. Oyler

Co-Founder, Chairman and CEO

BeiGene

Elaine Sorg

SVP, President, U.S. Commercial Operations

AbbVie

Chirfi Guindo

Chief Marketing Officer, Human Health

Merck

Dr. Michael Hayden

CEO

Prilenia

Cheryl MacDiarmid

SVP, Head of Global Commercial Strategy

ViiV Healthcare

Gadi Saarony

CEO

Advarra

James Robinson

CEO

Urovant Sciences

Dr. Patricia Hurter

CEO

Lyndra Therapeutics

Simba Gill, Ph.D.

CEO

Evelo Biosciences

Greg Rubert

SVP, Commercial Operations

Bausch Health

Diana M. Brainard

CEO

AlloVir

Navdeep Chadha

Co-founder & CTO

Axtria

Nadim Ahmed

President and CEO

Cullinan Oncology

Monika Williams

Vice President, Commercial Operations

Regeneron

Geert Kersten

CEO

CEL-SCI Corporation

Jeff Galvin

CEO and Founder

American Gene Technologies

Deanna Petersen

Chief Business Officer

AVROBIO

Bill Kerr, M.D.

CEO

Avalon Healthcare Solutions

Susan Dorfman

CEO

CMI Media Group

Steve Winawer

Head of Data, Digital, and Technology (US)

Takeda

Dr. Edward Kaye

CEO

Stoke Therapeutics

Tonya Villafana

VP, Global Franchise Head, Infection

AstraZeneca

Malai Sankarasubbu

VP, Engineering and Research

Saama

Athena Countouriotis, M.D.

President and CEO

Avenzo Therapeutics

Chris Cashwell

CEO & Founder

Azra AI

Sally Allain

Head of JLABS

Johnson & Johnson

Japan’s MHLW approves AstraZeneca and Moderna Covid-19 vaccines

Clinical Editorial Team - May 28, 2021 0

Japan’s Ministry of Health, Labour, and the Welfare department (MHLW) has approved Moderna’s COVID-19 mRNA vaccine and Vaxzevria

New Player Latigo in Pain Biotech Challenges Vertex

Commercial Editorial Team - February 19, 2024 0

A new contender has emerged in the domain of pain-focused biotechnology, marking...

Amgen’s Drug for Small Cell Lung Cancer Receives US FDA Approval

Regulatory Editorial Team - May 20, 2024 0

Recently, the U.S. Food and Drug Administration (FDA) approved Imdelltra, a new therapeutic agent...

Regenxbio And Nippon Sinyaku Pen $810M Gene Therapy Agreement

Commercial Editorial Team - January 16, 2025 0

Regenxbio has struck a strategic partnership valued at $810 million with Japan's Nippon Shinyaku...

Sling Therapeutics Challenges Tepezza in Thyroid Eye Disease Treatment

Clinical Editorial Team - January 16, 2025 0

Sling Therapeutics has achieved a milestone in the development of its oral treatment for...

Umoja Biopharma Secures $100 Million Series C Funding for Cell Therapy Advancements

Commercial Editorial Team - January 16, 2025 0

Umoja Biopharma has successfully closed a $100 million Series C funding round, marking a...

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

LifeNewsLife Science

LifeNewsFashion Trends and Culture

LifeSciVoiceFashion Trends and Culture

LifeNewsFashion Trends and Culture

Top Industry Leaders Award Winners 2022 - Complete List

Victor Bulto

John C. Jacobs

Alisha Alaimo

Frank D. Lee

John V. Oyler

Elaine Sorg

Chirfi Guindo

Dr. Michael Hayden

Cheryl MacDiarmid

Gadi Saarony

James Robinson

Dr. Patricia Hurter

Simba Gill, Ph.D.

Greg Rubert

Diana M. Brainard

Navdeep Chadha

Nadim Ahmed

Monika Williams

Geert Kersten

Jeff Galvin

Deanna Petersen

Bill Kerr, M.D.

Susan Dorfman

Steve Winawer

Dr. Edward Kaye

Tonya Villafana

Malai Sankarasubbu

Athena Countouriotis, M.D.

Chris Cashwell

Sally Allain

Editor Picks

Must Read

Hot Topics

LifeSciVoice

About Us

Follow Us